Autopsy report · NCT00901836

Preoperative Proton Radiotherapy for Retroperitoneal Sarcoma

“Study closed due to feasability”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 3 years 6 months before it stopped.
• 2 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

University of Florida

Sponsor type

University, hospital or other

Conditions

Retroperitoneal Sarcoma

Interventions

Preoperative proton therapy; Surgery

Participants

2

Sites

1

Countries

United States

Trials that died the same way

• High Dose Rate Brachyablation of Primary Liver Lesions
  “Study was closed due to poor accrual” (76% match in meaning)
• Checkpoint Inhibitor and Radiation Therapy in Bulky, Node-Positive Bladder Cancer
  “Study was closed to low accrual.” (72% match in meaning)
• A Supportive Care Intervention for Older Caregivers of Older Adults with Advanced Cancer
  “Study has been closed to accrual earlier than anticipated and will not resume.” (70% match in meaning)
• Human IL-15 (rhIL-15) and Obinutuzumab for Relapsed and Refractory Chronic Lymphocyte Leukemia
  “The study was closed after \> 1 year of inactivity.” (70% match in meaning)
• Treosulfan-Based Versus Clofarabine-Based Conditioning Before Donor Hematopoietic Stem Cell Transplant for the Treatment of Myelodysplastic Syndromes or Acute Myeloid Leukemia
  “The study was closed due to the end of funding.” (69% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.